Fundraising Fox

Cyrcadia

Reno, US · Nevada corporation

Cyrcadia Health develops the Cyrcadia Breast Monitor, a pair of wearable breast patches that detect circadian temperature changes in breast tissue and apply machine learning algorithms to identify abnormal patterns, delivering results to health care providers. The product targets women seeking early breast health monitoring and is not currently available for sale in the United States.

Founders & leadership

RR
Rob RoyeaExecutive
JD
Jim D HolmesTreasurer and Corporate Secretary
JD
Jim D. HolmesNamed on SEC filing

Board

SM
Shyamali Mallick SinghalBoard director
MB
Matthew BenardisBoard director
CS
Constance SkidmoreBoard director
JM
John MoriartyBoard director

Reported raises · per SEC filings

Form D private placements

$2.4M disclosed across 2 rounds · 2012–2015

$300KraisedDec 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shyamali Mallick SinghalDirector
  • Matthew BenardisDirector
  • Constance SkidmoreDirector
  • Rob RoyeaExecutive Officer, Director
  • Jim D HolmesDirector
  • John MoriartyDirector
Offering amount
$1.2M
Amount sold
$300K
Minimum investment
$50K
First sale
Nov 2015
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.1MraisedSep 2014 · 62 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jim D. HolmesExecutive Officer, Director
Offering amount
$3M
Amount sold
$2.1M
Minimum investment
$5K
First sale
Sep 2012
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Cyrcadia for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Cyrcadia do?
Cyrcadia Health develops the Cyrcadia Breast Monitor, a pair of wearable breast patches that detect circadian temperature changes in breast tissue and apply machine learning algorithms to identify abnormal patterns, delivering results to health care providers. The product targets women seeking early breast health monitoring and is not currently available for sale in the United States.
How much funding has Cyrcadia raised?
Cyrcadia has disclosed $2.4M raised across 2 rounds.
Where is Cyrcadia headquartered?
Cyrcadia is headquartered in Reno, US.